SCHEMBL19633926

SCHEMBL19633926

COc1ccc(CN(Sc2ccc(OC3CCN(C(=O)OC(C)(C)C)CC3(C)C)c(Cl)c2)c2ncns2)c(OC)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STS P08842 1/20 0.36
P2RX3 P56373 1/20 0.36
SCN1A P35498 2/20 0.36
SCN8A Q9UQD0 2/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
PDE4B Q07343 4/20 0.35
PDE4A P27815 3/20 0.35
PDE4C Q08493 3/20 0.35
PDE4D Q08499 3/20 0.35
MAPT P10636 2/20 0.35
EPHX2 P34913 1/20 0.34
PIK3CD O00329 2/20 0.32
PIK3CA P42336 2/20 0.32
PIK3CB P42338 2/20 0.32
PIK3CG P48736 2/20 0.32
BACE1 P56817 2/20 0.32
CTSD P07339 1/20 0.32
CTSE P14091 1/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19613593 0.85 SCN8A (0.42) STSP2RX3SCN1ASCN8AMEN1
SCHEMBL19627593 0.81 SCN8A (0.42) STSSCN1ASCN8AMEN1KMT2A
SCHEMBL19634012 0.80 PDE4B (0.41) STSP2RX3SCN1ASCN8AMEN1
SCHEMBL19634031 0.78 STS (0.36) STSP2RX3SCN1ASCN8AMEN1
SCHEMBL19634256 0.77 P2RX3 (0.37) STSP2RX3SCN1ASCN8AMEN1
SCHEMBL19634114 0.75 SCN1A (0.37) P2RX3SCN1ASCN8AMEN1KMT2A
SCHEMBL28528260 0.74 STS (0.39) STSP2RX3SCN1ASCN8AMEN1
SCHEMBL19634176 0.72 P2RX3 (0.36) STSP2RX3MEN1KMT2AMAPT
SCHEMBL19617773 0.72 SCN1A (0.37) SCN1ASCN8AMEN1KMT2AMAPT
SCHEMBL19634129 0.71 SCN8A (0.47) SCN1ASCN8AMEN1KMT2ABACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017201468-A1 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2017-11-23 WO disclosed